← Back to patent-cliff list
酒石酸西尼必利
Tier C — Watch / tradeCinitapride Tartrate
Almirall Sa
Originator
1990
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：5-HT2、5-HT4、5-HT1A
Brand：Pemix、Blaston、Cidine、Cinigest、希笛尼
Indications (approved)：消化不良、胃肌轻瘫、胃食管反流病
Regional status
US
-
EU
批准上市
1990-01-01
China
批准上市
2015-02-10
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Cinitapride Tartrate?
Approved indications include: 消化不良, 胃肌轻瘫, 胃食管反流病.
When does the Cinitapride Tartrate patent expire?
No public expiry year is available for Cinitapride Tartrate yet; this page updates once verified.
How do I get a quote for Cinitapride Tartrate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25